|
Index of reports
> Cases resulting in disability (1)
> Cases with Ventricular Extrasystoles (1)
Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in disability where reactions include ventricular extrasystoles.
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-03-08
Patient: female
Adverse reactions / side effects: Nipple Pain, Breast Cancer in Situ, Electrocardiogram Ambulatory Abnormal, Mammogram Abnormal, Laboratory Test Abnormal, Palpitations, Uterine Leiomyoma, Chest Pain, Injury, Ventricular Extrasystoles, Intervertebral Disc Protrusion, Nausea, Supraventricular Extrasystoles, Arrhythmia, Emotional Distress, Anxiety, Rhinitis Allergic, Syncope, Presyncope, Scar
Adverse event resulted in: disablity
Suspect drug(s):
Climara ^schering^
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-07-01
Estrace
Dosage: 1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-06-27
Premarin
Dosage: 0.062 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-03-08
Vivelle
Dosage: 0.05 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 1996-06-20
|
